J
JFL-RE
NSEJFL Life Sciences Ltd-RE (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹0.10
0.05 (33.33%)
As on 18 Mar 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹0 Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
N/A
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹0.1+0.0%
52W High₹0.15-33.3%
Current Price
₹0.10
Circuit Limits (40%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹0.06
Upper Circuit₹0.14
Reference Price
₹0.10
Investment Checklist
Analysis data not available yet
Technical Analysis
Financials
Financial data not available
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| JFL Life Sciences Ltd-RE | ₹0.10 | -33.33% | — | ₹0 Cr small Cap |
Corporate Information
Latest News
News for JFL-RE
View All
positive
Business Standard - Markets 3d ago
Pharma stocks: Lupin, Torrent hit new peaks; Sun nears summit; here's why
Pharma stock rally: Orchid Pharma, Hikal, Unichem Labs, IOL Chemicals, SPARC, RPG Life Sciences and Acutaas Chemicals surged up to 13% in Wednesday's trade.
ABGSECABSL10BANKABSLAMCABSLBANETFABSLLIQUIDABSLNN50ETABSLPSEACUTAASALIVUSBSLGOLDETFBSLNIFTYBSLSENETFGGSEC10ABSLHEALTHYHIKALIOLCPJFLLIFEJFL-REJGCHEMLUPINMOMENTUMNIFTYQLITYORCHPHARMARPGLIFESAILIFESILVERSOLARASPARCSUVENTECHChemicalsFinancial Services
negative
LiveMint - Companies 3d ago
Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection
The patented platform combines genome sequencing, methylation analysis and machine learning to detect cancer and identify its tissue of origin from a single blood sample.
ABGSECALIVUSJFLLIFEJFL-RERELIANCERELINFRARPGLIFESAILIFESUVENFinancial ServicesHealthcare
neutral
Google News - India Markets 8d ago
Market Trading Guide: Suven Life Sciences among 2 stock recommendations for Friday - The Economic Times
Market Trading Guide: Suven Life Sciences among 2 stock recommendations for FridayThe Economic Times
ALIVUSJFLLIFEJFL-RERPGLIFESAILIFESUVENHealthcare